NCT00280878View on ClinicalTrials.gov

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

September 30, 2007

Conditions
Non-Hodgkin's Lymphoma (CD20+)
Interventions
DRUG

gemcitabine

DRUG

vinorelbine

DRUG

ifosfamide

DRUG

rituximab

Trial Locations (2)

3004

The Alfred Hospital, Melbourne

Unknown

Frankston Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
lead

Bayside Health

OTHER_GOV

NCT00280878 - Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma | Biotech Hunter | Biotech Hunter